CIPO Patents = 2

EPO Patents = 8

Forward Citations = 197

Loading Chart...

8 inventors (with patents filed for the assignee):

Pascal Suplie (6 out of 23 patents)

Christophe Lebon (5 out of 7 patents)

David Olivier Paul (1 out of 1 patent)

4. Sylvie Lecoustey (1 out of 1 patent)

5. Fabrice Leboeuf (1 out of 2 patents)

6. Jennifer Jung (1 out of 2 patents)

7. Frantz Deschamps (1 out of 4 patents)

8. Julien Guiraud (1 out of 1 patent)

9. Philippe Vivet (0 patent)

10. Philippe Vivet (0 patent)

11. Guiraud Julien (0 patent)

7 patents: Sort by Forward Citations

1. 11690816 - Unit doses for immediate release of GHB or of one of the therapeutically acceptable salts thereof, administered orally, and the use thereof to maintain alcohol abstinence (2023-07-04),

2. 10441585 - Formulations containing nalbuphine and uses thereof (2019-10-15),

3. 9943488 - Gamma hydroxybutyric acid granules (2018-04-17),

4. 9782367 - Process for obtaining a modafinil-based pharmaceutical composition, resulting pharmaceutical composition and use thereof (2017-10-10),

5. 8999392 - Pharmaceutical formulations to prevent the misuse of medicinal drugs (2015-04-07),

6. 8916202 - Floating microgranules (2014-12-23),

7. 8529954 - Composition based on gamma-hydroxybutyric acid (2013-09-10),

Debregeas Et Associes Pharma is a leading pharmaceutical company specializing in the development and manufacturing of high-quality pharmaceutical products. With a focus on innovation and cutting-edge technology, the company is dedicated to improving the health and well-being of patients worldwide. Debregeas Et Associes Pharma is committed to excellence in research, development, and production, and strives to be a trusted partner in the global healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

7 Patents

#418 in Paris

#2,184 in France

Paris, France

Debregeas Et Associes Pharma

Forward Citations = 197

8 inventors:

Pascal Suplie (6 out of 23 patents)

Christophe Lebon (5 out of 7 patents)

David Olivier Paul (1 out of 1 patent)

4. Sylvie Lecoustey (1 out of 1 patent)

5. Fabrice Leboeuf (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com

2 patents (CIPO):

Please report any incorrect information to support@idiyas.com

8 patents (EPO):

Please report any incorrect information to support@idiyas.com